Addressing the Challenges of Tuberculosis: A Brief Historical Account

Addressing the Challenges of Tuberculosis: A Brief Historical Account

Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB an...

Full description

Bibliographic Details
Main Authors:	Hussam W. Al-Humadi, Rafal J. Al-Saigh, Ahmed W. Al-Humadi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-09-01
Series:	Frontiers in Pharmacology
Subjects:	tuberculosis history treatment anti-TB drugs multidrug resistance pharmaceutical innovation
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00689/full

Similar Items

Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience
by: Alena Skrahina, et al.
Published: (2016-01-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo
by: Michel Kaswa Kayomo, et al.
Published: (2018-11-01)

Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014–2015
by: Maha Al Ammari, et al.
Published: (2018-01-01)

Managing multidrug-resistant tuberculosis in hospitalized patients at Sizwe Tropical Diseases Hospital: A five year review of treatment outcomes
by: Njaramba, Peter
Published: (2006)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities
by: S.E. McAnaw, et al.
Published: (2017-03-01)

Multidrug-resistant tuberculosis: case reports study in a central state of Brazil
by: João Alves de Araújo-Filho, et al.

Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru
by: Ruvandhi R. Nathavitharana, et al.
Published: (2017-11-01)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
by: Julia Ershova, et al.
Published: (2015-11-01)

Pulmonary resection can improve treatment outcome in re-treatment pulmonary tuberculosis and its complications
by: Ali Rifaat, et al.
Published: (2014-04-01)

Strengthened tuberculosis control programme and trend of multidrug resistant tuberculosis rate in Osaka City, Japan
by: Nobukatsu Ishikawa, et al.
Published: (2013-02-01)

Oral Candida in Patients with Fixed Orthodontic Appliance: In Vitro Combination Therapy
by: Wisam Alhamadi, et al.
Published: (2017-01-01)

Factors associated with treatment success and death in cases with multidrug-resistant tuberculosis in Bulgaria, 2009–2010
by: Vladimir Milanov, et al.
Published: (2015-01-01)

Multidrug-resistant Tuberculosis Detection, Latvia
by: Girts Skenders, et al.
Published: (2005-09-01)

Tuberculosis and Human Immunodeficiency Virus Co-Infection and Associated Factors at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia: A Four-Year Retrospective Study
by: Alemu A, et al.
Published: (2021-03-01)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
by: Jay Achar, et al.
Published: (2015-11-01)

Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa
by: Marisa Klopper, et al.
Published: (2013-03-01)

HIV Infection and Geographically Bound Transmission of Drug-Resistant Tuberculosis, Argentina
by: Viviana Ritacco, et al.
Published: (2012-11-01)

Predominance of Beijing genotype in extensively drug resistant Mycobacterium tuberculosis isolates from a tertiary care hospital in New Delhi, India
by: Jyoti Arora, et al.
Published: (2013-01-01)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
by: Gunar Günther, et al.
Published: (2015-03-01)

First-line anti-tubercular drug resistance of Mycobacterium tuberculosis in IRAN: a systematic review
by: Babak Pourakbari, et al.
Published: (2016-07-01)

Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
by: Marie Jaspard, et al.
Published: (2017-10-01)

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
by: Guang Xue He, et al.
Published: (2011-10-01)

Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru
by: Hsien-Ho Lin, et al.
Published: (2012-05-01)

Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
by: Mabhula, Amanda N
Published: (2021)

GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
by: Saeed Muhammad, et al.
Published: (2020-06-01)

Predictors of Tuberculosis Treatment Default in Pulmonary Predictors of Tuberculosis Treatment Default in Pulmonary Predictors of Tuberculosis Treatment Default in Pulmonary Predictors of Tuberculosis Treatment Default in Pulmonary Predictors of Tuberculo
by: Khalid Mehmood
Published: (2017-09-01)

Primary Multidrug-Resistant Mycobacterium tuberculosis in 2 Regions, Eastern Siberia, Russian Federation
by: Svetlana Zhdanova, et al.
Published: (2013-10-01)

Impact of different tuberculosis history at the onset of future multidrug-resistant tuberculosis: A large, retrospective, population-based cohort study
by: Qinglin Cheng, PhD., et al.
Published: (2021-03-01)

Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis
by: Parvaneh Baghaei, et al.
Published: (2015-01-01)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
by: Pravin K. Singh, et al.
Published: (2019-09-01)

Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017
by: Priya Rathi, et al.
Published: (2020-05-01)

Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
by: Timothy Sullivan, et al.
Published: (2016-03-01)

Drug-Resistant Tuberculosis in Zhejiang Province, China, 1999–2008
by: Xiaomeng Wang, et al.
Published: (2012-03-01)

Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
by: John Z. Metcalfe, et al.
Published: (2010-09-01)

Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China
by: Li Y, et al.
Published: (2019-03-01)

Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear–Negative Drug-Resistant Tuberculosis, China
by: Fei Huang, et al.
Published: (2019-07-01)

Spread of Extensively Drug-resistant Tuberculosis
by: Sofía Samper, et al.
Published: (2007-04-01)

Microbiome in sputum as a potential biomarker of chronicity in pulmonary resistant to rifampicin-tuberculosis and multidrug-resistant-tuberculosis patients
by: Nurul Wiqoyah, et al.
Published: (2021-01-01)